INS and obesity disorder: Relevant to obesity, evaluation in mouse models have indicated that the combination of dasatinib and quercetin reduces inflammation, alleviates metabolic dysfunction pre-adiposity, and facilitates the differentiation of adipose cells into mature, insulin-responsive ones (88).